Ocular Hypertension Clinical Trials

A listing of Ocular Hypertension medical research trials actively recruiting patient volunteers. Use the filters below to narrow your search results.

 

Arizona

Chandler Arizona 85225

A Phase 2 clinical study for patients with Ocular Hypertension or Open-Angle Glaucoma

Phoenix Arizona 85050

A Phase 2 clinical study for patients with Ocular Hypertension or Open-Angle Glaucoma

Arkansas

Fayetteville Arkansas 72704

A clinical trial to evaluate treatments using OTX-TP and Timolol for patients with Glaucoma or Ocular Hypertension

California

Artesia California 90701

A clinical research study for the treatment of Open Angle Glaucoma or Ocular Hypertension

Petaluma California 94954

A clinical research study for the treatment of Open Angle Glaucoma or Ocular Hypertension

San Francisco California 94105

A clinical study for patients with Primary Open Angle Glaucoma, Ocular Hypertension, Pseudo-Exfoliative Glaucoma or Pigment Dispersion Glaucoma

Torrance California 90505

A Phase 2 clinical study for patients with Ocular Hypertension or Open-Angle Glaucoma

Torrance California

Patients are needed to participate in a clinical research study evaluating Bimatoprost sustained-release, Sham, Timolol and Timolol Vehicle (placebo) for the treatment of Glaucoma, Open-Angle or Ocular Hypertension

Connecticut

New Haven Connecticut 06510

A clinical research study of Sensimed Triggersfish® for the treatment of Ocular Hypertension

Florida

Cape Coral Florida 33904

A Phase 2 clinical study for patients with Ocular Hypertension or Open-Angle Glaucoma

Fort Myers Florida 33901

A Phase 2 clinical study for patients with Ocular Hypertension or Open-Angle Glaucoma

Maitland Florida 32751

A clinical trial to evaluate treatments using Preservative free tafluprost opthalmic solution for patients with Glaucoma or Ocular Hypertension

Georgia

Morrow Georgia 30260

A clinical research study for the treatment of Open Angle Glaucoma or Ocular Hypertension

Illinois

Wheaton Illinois

A clinical study for patients with Open-Angle Glaucoma or Ocular Hypertension

Indiana

Indianapolis Indiana 46202

A Phase 2 clinical study for patients with Ocular Hypertension or Open-Angle Glaucoma

Kentucky

Edgewood Kentucky 41017

A Phase 2 clinical study for patients with Ocular Hypertension or Open-Angle Glaucoma

Louisville Kentucky 40217

A clinical research study for the treatment of Open Angle Glaucoma or Ocular Hypertension

Michigan

St. Joseph Michigan 49085

A Phase 2 clinical study for patients with Ocular Hypertension or Open-Angle Glaucoma

Minnesota

Bloomington Minnesota 55420

A Phase 2 clinical study for patients with Ocular Hypertension or Open-Angle Glaucoma

Missouri

St. Louis Missouri 63131

A Phase 2 clinical study for patients with Ocular Hypertension or Open-Angle Glaucoma

Washington Missouri 63090

A Phase 2 clinical study for patients with Ocular Hypertension or Open-Angle Glaucoma

Nevada

Las Vegas Nevada 89148

A Phase 2 clinical study for patients with Ocular Hypertension or Open-Angle Glaucoma

New Jersey

UPDATED

Bedminster New Jersey 07921

A Phase 3 clinical study for patients with Ocular Hypertension. or Glaucoma

New York

Lynbrook New York 11563

A Phase 2 clinical study for patients with Ocular Hypertension or Open-Angle Glaucoma

Slingerlands New York 12159

A Phase 2 clinical study for patients with Ocular Hypertension or Open-Angle Glaucoma

North Carolina

High Point North Carolina 27262

Patients are needed to participate in a clinical research study of Combigan BID and Simbrinza TID to evaluate Glaucoma or Ocular Hypertension

Research Triangle Park North Carolina 27709

Patients are needed to participate in a clinical research study evaluating ENV515 Travoprost XR and TRAVATAN Z for the treatment of Glaucoma and Ocular Hypertension

Pennsylvania

Philadelphia Pennsylvania 19107

A Phase 2 clinical study for patients with Ocular Hypertension or Open-Angle Glaucoma

Philadelphia Pennsylvania 19148

A Phase 2 clinical study for patients with Ocular Hypertension or Open-Angle Glaucoma

Tennessee

Maryville Tennessee 37803

A Phase 2 clinical study for patients with Ocular Hypertension or Open-Angle Glaucoma

Memphis Tennessee 38119

A Phase 2 clinical study for patients with Ocular Hypertension or Open-Angle Glaucoma

Texas

Austin Texas

A Phase 3 clinical study for patients with Open-Angle Glaucoma or Ocular Hypertension

Mission Texas 78572

A clinical trial to evaluate treatments using Preservative free tafluprost opthalmic solution for patients with Glaucoma or Ocular Hypertension

San Antonio Texas 78229

A clinical trial to evaluate treatments using Open angle glaucoma - iDropper device for patients with Glaucoma, Open-Angle

Washington

Bellevue Washington

Patients are needed to participate in a clinical research study evaluating VS101 Insert Dose A, VS101 Insert Dose B, VS101 Insert Dose C and Latanoprost 0.005% eye drops for the treatment of Open Angle Glaucoma or Ocular Hypertension

Armenia

Yerevan 375108

A Phase 4 clinical study for patients with Primary Open Angle Glaucoma (POAG)

Yerevan 0001

Patients are needed to participate in a clinical research study evaluating iStent inject and Travoprost for the treatment of Open-angle Glaucoma

Australia

Melbourne Victoria

A Phase 3 clinical study for patients with Open-Angle Glaucoma or Ocular Hypertension

Bulgaria

Sofia 1408

Patients are needed to participate in a clinical research study of CF101 and Placebo to evaluate Ocular Hypertension or Glaucoma

Sofia 1527

Patients are needed to participate in a clinical research study of CF101 and Placebo to evaluate Ocular Hypertension or Glaucoma

China

Beijing 100016

A Phase 3 clinical study for patients with Open-Angle Glaucoma (OAG) or Ocular Hypertension (OHT)

Estonia

Tallin 10138

A clinical research study for the treatment of Open Angle Glaucoma or Ocular Hypertension

Tallin 13419

A clinical research study for the treatment of Open Angle Glaucoma or Ocular Hypertension

Tartu 50406

A clinical research study for the treatment of Open Angle Glaucoma or Ocular Hypertension

France

Clermont ferrand 63000

Patients are needed to participate in a clinical research study of Monoprost, Lumigan 0.01% and Lumigan 0.03% Unit Dose to evaluate Primary Open Angle Glaucoma or Ocular Hypertension

Germany

Freiburg 79106

A clinical research study for the treatment of Open Angle Glaucoma or Ocular Hypertension

Magdeburg 39106

A clinical research study for the treatment of Open Angle Glaucoma or Ocular Hypertension

Munich 80336

A clinical research study for the treatment of Open Angle Glaucoma or Ocular Hypertension

Munster D-48149

A clinical research study for the treatment of Open Angle Glaucoma or Ocular Hypertension

Regensburg 93053

A clinical research study for the treatment of Open Angle Glaucoma or Ocular Hypertension